Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical

The pandemic brought about a change in the way people look at technology. 2021 proves to be the development of a new era of technology where AI is at the core.

According to McKinsey’s Global Survey on artificial intelligence (AI) 2020, organizations are using AI as a tool for generating value in the form of revenues. Some executives have even observed that implementing AI has brought about a change of 20% in the organizations’ earnings. The COVID-19 pandemic has accelerated the concept of ‘all things digital’, and these companies plan to invest more in AI.

Read more | >

Name: Travis Chen and Brian Femminella

Age: 22 and 21

Location: Seattle, Washington; Los Angeles, California.

Business: SoundMind, a music therapy app designed for those experiencing trauma, depression 0, and anxiety.

Read more | >

Informed consent not something we hear a lot about these days, which is kind of odd, given all the drugs our government currently insists that we take and how often those very same legal concepts are invoked for aboriginal rights and sexual assault cases.

“Informed consent” is a well understood legal doctrine in healthcare, requiring the healthcare provider (traditionally a doctor) to educate patients about the risks, benefits, and alternatives of any given recommended procedure or intervention, allowing the patient to make informed and “voluntary” decisions about whether to undergo the procedure.

Read more | >

Some Drosophila species have cryptic sex-ratio drive systems. Here, the authors show rapid expansion of a driver gene family, Distorter on the X, in three closely related Drosophila species on the X chromosome and suppressors on the autosomes.

Read more | >

No, it’s not from a science fiction movie or from an episode of a popular kid’s television show. It’s real life. Researchers, in a proof-of-concept study, have made fish-shaped microrobots that are guided with magnets to cancer cells, where a pH change triggers them to open their mouths and release their chemotherapy cargo.

Scientists have previously made microscale (smaller than 100 µm) robots that can manipulate tiny objects, but most can’t change their shapes to perform complex tasks, such as releasing drugs. Some groups have made 4D-printed objects (3D-printed devices that change shape in response to certain stimuli), but they typically perform only simple actions, and their motion can’t be controlled remotely.

In a step toward biomedical applications for these devices, Jiawen Li, Li Zhang, Dong Wu and colleagues wanted to develop shape-morphing microrobots that could be guided by magnets to specific sites to deliver treatments. Because tumors exist in acidic microenvironments, the team decided to make the microrobots change shape in response to lowered pH.

Read more | >

The vaccine candidate was originally developed by the Israel Institute for Biological Research (IIBR), which operates under the auspices of the Prime Minister’s Office and works closely with the Defense Ministry.

The institute’s strategic and technical capabilities are shrouded in secrecy, but this week, The Jerusalem Post gained access to new data that show BriLife could be more effective against mutations and confer lasting immunity.

The Israeli vaccine could potentially address COVID better than other technologies, according to the CEO of NeuroRx.

Read more | >

Oramed Pharmaceuticals, the developer of the Oravax oral COVID-19 vaccine candidate, has announced a partnership with Mexico’s Genomma Lab Internacional to help fast-track a Phase II clinical trial and gain emergency use authorization in the Latin American country.

Only about 58% of Mexico’s population has been jabbed with one dose of a coronavirus vaccine, averaging around 4,500 new cases per day.

Read more | >

The Biden administration is expected to announce this week it is purchasing 10 million courses of treatment Pfizer’s covid pill, a multibillion dollar investment in a medication that officials hope will help change the trajectory of the pandemic by staving off many hospitalizations and deaths, according to two people with knowledge of the transaction.

-call me Nostradamus, but I called this.

Officials see Pfizer’s pill, and another by Merck, as potential gamechangers to tame the pandemic.

Read more | >

Freedom of Information Act requests are rarely speedy, but when a group of scientists asked the federal government to share the data it relied upon in licensing Pfizer’s COVID-19 vaccine, the response went beyond typical bureaucratic foot-dragging.

55 years and longer.

That’s how long the Food & Drug Administration in court papers this week proposes it should be given to review and release the trove of vaccine-related documents responsive to the request. If a federal judge in Texas agrees, plaintiffs Public Health and Medical Professionals for Transparency can expect to see the full record in 2076.

Read more | >

“Fountain is an example of a biotech company emerging as a direct result of basic research, in this case the biology of aging,” said Dr Rando, founder and chairman of Fountain. “The company’s screening and discovery platform is built upon foundational research showing that the age of a cell can be modulated by factors in the cell’s environment. By identifying compounds that work through these pathways, we seek to restore youthful resilience to cells and tissues, leading to therapies that treat or even prevent chronic diseases of aging.”

Longevity funding: Eli Lilly and R42 Group join the party as Khosla-backed biopharma brings total Series A to $26 million.

Read more | >